Solution Structure of the Phosphotyrosine Binding (PTB) Domain of Human Tensin2 Protein in Complex with Deleted in Liver Cancer 1 (DLC1) Peptide Reveals a Novel Peptide Binding Mode

Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation

(2012) X. Cao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

DLC1 Interaction with S100A10 Mediates Inhibition of In Vitro Cell Invasion and Tumorigenicity of Lung Cancer Cells through a RhoGAP-Independent Mechanism

(2011) X. Yang et al.   CANCER RESEARCH

Solution Structure of Tensin2 SH2 Domain and Its Phosphotyrosine-Independent Interaction with DLC-1

(2011) Kun Dai et al.   PLoS One

Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK)

(2011) G. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects

(2009) Sassan Hafizi et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

DLC1 Activation Requires Lipid Interaction through a Polybasic Region Preceding the RhoGAP Domain

(2009) Patrik Erlmann et al.   MOLECULAR BIOLOGY OF THE CELL

Deleted in Liver Cancer 1 (DLC1) Utilizes a Novel Binding Site for Tensin2 PTB Domain Interaction and Is Required for Tumor-Suppressive Function

(2009) Lo-Kong Chan et al.   PLoS One

Mutations in the Focal Adhesion Targeting Region of Deleted in Liver Cancer-1 Attenuate Their Expression and Function

(2008) Y.-C. Liao et al.   CANCER RESEARCH

DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma

(2008) W. Xue et al.   GENES & DEVELOPMENT

DLC1: a significant GAP in the cancer genome

(2008) A. Lahoz et al.   GENES & DEVELOPMENT

The PTB domain of tensin: NMR solution structure and phosphoinositides binding studies

(2007) Marilisa Leone et al.   BIOPOLYMERS